Hyperammonemic encephalopathy after 5-fluorouracil chemotherapy
Canadian Medical Association Journal · 19.01.2026 · 198 (2) · E44-E47
DOI: 10.1503/cmaj.251206 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Medical Association Journal, online erschienen am 18.01.2026. Verfasst von Payam Salimi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine (Salimi, Soriano), and Sections of General Internal Medicine (Crocker) and Medical Oncology and Hematology (Goldenber…. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Internal Medicine (Salimi, Soriano), and Sections of General Internal Medicine (Crocker) and Medical Oncology and Hematology (Goldenberg), Department of Internal Medicine, University of Manitoba, Winnipeg,…
Zitieren
APA
Salimi, P., Soriano, A., Crocker, E., & Goldenberg, B. (2026). Hyperammonemic encephalopathy after 5-fluorouracil chemotherapy. Canadian Medical Association Journal, 198(2), E44-E47. https://doi.org/10.1503/cmaj.251206
Vancouver
Salimi P, Soriano A, Crocker E, Goldenberg B. Hyperammonemic encephalopathy after 5-fluorouracil chemotherapy. Canadian Medical Association Journal. 2026;198(2):E44-E47. doi:10.1503/cmaj.251206
BibTeX
@article{Salimi2026,
author = {Salimi, Payam and Soriano, Andrea and Crocker, Elise and Goldenberg, Benjamin},
title = {Hyperammonemic encephalopathy after 5-fluorouracil chemotherapy},
journal = {Canadian Medical Association Journal},
year = {2026},
volume = {198},
number = {2},
pages = {E44--E47},
doi = {10.1503/cmaj.251206}
}
EUVIMED